Diabetes is a chronic disease that affects millions of people worldwide. It occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar. Both forms of diabetes are serious medical conditions that reduce life expectancy if left untreated. With advances in diabetes research and management of the disease, people living with diabetes are able to maintain healthy, productive lives.
There are currently three main types of diabetes identified through medical research: type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 1 diabetes, formerly known as juvenile diabetes or insulin-dependent diabetes, is a condition in which the body does not produce insulin due to damage to the insulin-producing beta cells of the pancreas. Researchers believe type 1 diabetes is caused by an autoimmune response in which the body attacks and destroys its own insulin-producing cells. Today, type 1 diabetes accounts for approximately 5-10% of all diagnosed cases of diabetes. It typically begins in childhood or early adulthood but can develop later in life as well. People with type 1 diabetes must take insulin daily to regulate their blood sugar levels.
Type 2 diabetes is the most common form of the disease and makes up about 90-95% of all diabetes cases. It develops when the body becomes resistant to the effects of insulin and/or does not produce enough insulin to maintain normal glucose levels. Type 2 diabetes is strongly associated with lifestyle factors such as obesity, poor diet, and physical inactivity. Genetics may also play a role in determining one’s risk for developing type 2 diabetes. While type 2 diabetes historically developed later in life, the rising rates of childhood obesity have led to more children and adolescents being diagnosed with this type of diabetes in recent decades. The management of type 2 diabetes involves lifestyle changes, oral medication, insulin therapy, or sometimes a combination of these approaches.
Gestational diabetes develops in some women during pregnancy when the hormones of pregnancy affect how the body processes sugar and insulin. It usually disappears after giving birth but puts mothers at higher risk of developing type 2 diabetes later in life. Research indicates children of mothers who had gestational diabetes also face increased health risks. The causes of gestational diabetes are not fully understood, but factors such as obesity, family history of diabetes, ethnicity, and maternal age may play a role in susceptibility. Good control of blood sugar levels during pregnancy helps mitigate complications for both mother and baby. Screening for gestational diabetes is routinely recommended between 24-28 weeks of gestation for pregnant women.
While the specific causes of each type of diabetes are different, all forms develop as a result of the body’s inability to properly regulate blood glucose levels. Excess glucose, or sugar, in the blood is toxic and can damage many of the body’s systems over time if blood sugar is not well-managed. Diabetes research focuses on advancing understanding of disease mechanisms, improving methods of prevention and treatment, developing enhanced monitoring and insulin delivery systems, studying long-term complications, and working towards a cure.
When it comes to prevention, type 1 diabetes currently cannot be prevented as the cause is not fully known. Researchers aim to identify environmental triggers and biomarkers that may help elucidate risks. For type 2 diabetes, lifestyle modifications through a healthy diet, regular physical activity, and weight management can significantly reduce risk. Numerous large cohort studies have provided compelling evidence on lifestyle factors and disease development. Much diabetes prevention research now targets high-risk groups like those with prediabetes or a family history of type 2 diabetes.
Medication management of diabetes has also evolved significantly due to continuous research efforts. Nearly 100 years ago, insulin was first used clinically to treat diabetes, revolutionizing care for those with type 1 diabetes. Since then, discovery of numerous oral hypoglycemic drugs as well as variations of insulin formulations have greatly expanded treatment options depending on disease severity and individual factors. Today, investigators are developing improved insulin delivery methods like inhaled insulin and insulin patches to provide more flexibility and convenience. Other promising areas of research involve new classes of antidiabetic agents that mimic the effects of the incretin hormones GLP-1 or work via novel mechanisms.
Monitoring of diabetes has also advanced with diabetes research. Self-monitoring of blood glucose using home glucometers that provide rapid results has long been an essential self-care practice. More recently, continuous glucose monitoring systems using interstitial fluid sensors have become available, offering real-time glucose readings without the need for fingersticks. These innovative monitoring technologies enable much finer glucose control and are especially beneficial for those with hypoglycemia unawareness or unstable glucose levels. Researchers continue advancing sensor miniaturization and accuracy to facilitate expanded use. New non-invasive methods of glucose monitoring are also areas of ongoing study.
One important focus in diabetes research is preventing and delaying complications associated with chronic hyperglycemia. Short-term complications like hypoglycemia and long-term consequences involving damage to organs and tissues such as the eyes, kidneys, nerves, heart, and blood vessels are major diabetes health burdens. By investigating disease mechanisms behind complications at the molecular level, researchers strive to identify new drug targets and biomarkers for early detection of microvascular and macrovascular changes. Clinical trials also evaluate lifestyle and medical therapies aimed at complication prevention and treatment. As lifespans increase for those with diabetes, investigating cognitive changes and dementia risk is another imperative avenue of inquiry.
Despite significant progress, a cure for diabetes remains elusive and continued research toward this goal is crucial. Stem cell research into replacing pancreatic beta cells and regenerating insulin production holds promise. Other cure-focused areas exploring immune therapies for type 1 diabetes, gene therapies, transdifferentiation techniques, and implantable bioengineered pancreases are hopeful yet ongoing pursuits. Major hurdles involve achieving sufficient functional beta cell mass and long-term durability while avoiding immune rejection. Collaborative international research efforts through organizations like the International Diabetes Federation aim to accelerate progress on cure-oriented aims.
Innovations building from past and ongoing diabetes research have undoubtedly enhanced care and outcomes. Yet diabetes remains a serious global health issue impacting countless lives and health systems. Further research advancements will be key to overcoming this disease. Given continued growth in diabetes prevalence worldwide, enhanced prevention and management approaches as well as progress toward a cure are desperately needed. With sustained support and collaborative efforts across disciplines, the journey of diabetes research looks hopeful for increasingly impactful discoveries that stand to significantly benefit those living with or at risk for this complex condition.
Andrew Stroud